Bhattacharya A, Travis D, Osterman MT, Lewis JD, et al. Supratherapeutic Infliximab Levels Do Not Predict Risk of Short-term Complications in Adults With Crohn's Disease. J Clin Gastroenterol 2023;57:66-73.
PMID: 34907922